How Much Did PetaGene Raise?
Funding & Key Investors

PetaGene has successfully secured a major strategic investment, marking a pivotal moment in its trajectory within the bioinformatics sector. With a total funding amount reaching $2.1M, the company continues to solidify its market presence. This recent funding amount of $2.1M serves as a catalyst for scaling its proprietary lossless compression technology, which is increasingly vital for the high-throughput genomic research landscape. By addressing the critical bottleneck of data storage and transfer, PetaGene is positioning itself as an essential infrastructure provider for global healthcare institutions.

The capital infusion underscores investor confidence in the company's ability to optimize BAM and FASTQ file management. As genomic datasets grow exponentially, the demand for efficient, high-performance solutions like PetaSuite becomes paramount. This financing round enables the firm to accelerate its product roadmap and expand its footprint among top-tier research organizations.

What is PetaGene?

PetaGene
SoftwareStorage & System Management Software

PetaGene specializes in advanced lossless genomic data compression software, a niche yet critical segment of the life sciences technology market. Its flagship products, PetaSuite and PetaSuite Cloud Edition, provide a seamless interface for researchers to access compressed files without the overhead of traditional decompression processes. By achieving storage savings of 60% to 90%, the company directly addresses the escalating costs associated with large-scale genomic sequencing. Its client base includes prestigious entities such as AstraZeneca and the Princess Máxima Center for Pediatric Oncology, validating the utility of its software in high-stakes clinical and research environments.

How much funding has PetaGene raised?

PetaGene has raised a total of $2.1M across 1 funding round:

2018

Unspecified

$2.1M

Unspecified (2018): $2.1M with participation from Romulus Capital, Greylock Partners, and Entrepreneur First

Key Investors in PetaGene

Romulus Capital

An early-stage venture capital firm that focuses on leading Seed and Series A rounds for B2B companies and deep technology firms emerging from elite research groups.

83North

A global venture capital firm managing over $2.2 billion, investing in exceptional entrepreneurs at all stages to build category-leading companies.

Entrepreneur First

An international talent investor established in 2011 that supports individuals in building and scaling technology companies from the ground up.

What's next for PetaGene?

Looking ahead, PetaGene is well-positioned to leverage this major enterprise-level funding to deepen its integration within cloud-native genomic workflows. The strategic focus will likely shift toward enhancing interoperability with existing bioinformatics pipelines and expanding its global sales reach. As the industry moves toward more data-intensive personalized medicine, PetaGene's ability to maintain performance while reducing storage footprints will be a key differentiator. The company is expected to prioritize R&D to maintain its competitive edge in data management, ensuring that its solutions remain the gold standard for institutions managing massive, complex genomic datasets.

See full PetaGene company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Customer Engagement PlatformsSoftware
Healthcare SoftwareSoftwareBusiness ServicesSoftware Testing
Engineering SoftwareSoftwareContent & Collaboration Software
Customer Engagement PlatformsSoftware

Frequently Asked Questions Regarding PetaGene Financial Insights

What are the most recent funding rounds that PetaGene has completed, and what were the funding rounds?
PetaGene has recently completed 1 funding rounds: Unspecified on Dec 26, 2018.
What is the total amount of funding PetaGene has raised to date?
PetaGene has raised a total of $2.1M in funding to date.
How many funding rounds has PetaGene completed?
PetaGene has completed 1 funding rounds.
How much funding did PetaGene raise in its most recent funding round?
PetaGene raised $2.1M in its most recent funding round.
Who are the lead investors in PetaGene's latest funding round?
The lead investor in PetaGene's latest funding round was Romulus Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in PetaGene's history?
The largest funding round in PetaGene's history was $2.1M.
See more information about PetaGene